Eliquis Regulatory Post Marketing Surveillance (rPMS)
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The objective of this regulatory Post-Marketing Surveillance in Korea is to reconfirm the
clinical usefulness of Eliquis through collecting, reviewing, identifying and verifying the
safety and effectiveness information about Eliquis in general practice